v3.20.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Dec. 31, 2020
Mar. 31, 2020
Current assets    
Cash $ 12,131,593 $ 9,604,780
Accounts receivable 114,849 206,729
Prepaid expenses and other current assets 75,829 229,604
Total current assets 12,322,271 10,041,113
Property and equipment, net 166,751 140,484
Right-of-use lease asset 64,750 136,426
Patents, net 57,092 57,504
Restricted cash 46,726 0
Deposits 12,159 12,159
Total assets 12,669,749 10,387,686
Current liabilities    
Accounts payable 175,422 285,036
Due to related parties 131,746 111,707
Deferred revenue 0 100,000
Lease liability, current portion 67,698 98,557
Other current liabilities 860,697 472,420
Total current liabilities 1,235,563 1,067,720
Lease liability, less current portion 0 42,540
Total liabilities 1,235,563 1,110,260
Commitments and Contingencies (Note 13)
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 12,123,524 and 9,366,873 shares issued and outstanding as of December 31, 2020 and March 31, 2020, respectively 12,125 9,368
Additional paid-in capital 129,207,491 121,426,563
Accumulated deficit (117,650,120) (112,026,381)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 11,569,496 9,409,550
Noncontrolling interests (135,310) (132,124)
Total stockholders' equity 11,434,186 9,277,426
Total liabilities and stockholders' equity $ 12,669,749 $ 10,387,686

Source